Efficacy of Dotarem® (Gd-DOTA) Versus Gadovist® (Gd-DO3A-butrol) for Late Gadolinium Enhancement Cardiac Magnetic Resonance

NCT03057561 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease
Cardiomyopathy

Interventions

DRUG: Cardiac MRI taken using contrast agent, Dotarem® (Gd-DOTA)
DRUG: Cardiac MRI with contrast agent, Gadovist

Sponsor

The Methodist Hospital Research Institute

Collaborators

[object Object]